Clin2
NCT06979115Likely a fitNot yet recruiting

Glowing dye to guide removal of bone and soft tissue tumors

Bone NeoplasmsSoft Tissue Neoplasms

Treatments studied

Part of Bones, joints & muscles, Cancer clinical trials.

This study uses a special dye that makes tumors glow during surgery, helping your surgeon see exactly what to remove and what to leave. It aims to make surgery more precise and safer for people with bone or soft tissue tumors.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
Any age
Study type
Observational

Who can take part

  • You have a confirmed bone or soft tissue tumor (diagnosed by a biopsy).
  • You are healthy enough to have surgery, based on your doctor's checkup.
  • You do not have severe or ongoing problems with your kidneys, liver, or lungs.
  • You do not have a thyroid condition or an allergy to iodine or shellfish.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07315828Recruiting· Phase 4
ICG imaging to improve surgery for giant cell bone tumors

This trial uses a special dye called indocyanine green (ICG) during surgery to make giant cell bone tumors glow, helping doctors remove them more accurately. It may lead to better surgical outcomes for people with this tumor type.

Shanghai
NCT04752137Recruiting· Phase 2
ICG dye imaging during surgery to check tumor edges

This trial tests whether a special dye (ICG) seen during your surgery can help doctors better identify the edges of a tumor in bone or soft tissue. It may help ensure as much of the tumor is removed as safely as possible.

Boston, Massachusetts
NCT06647901Recruiting· Phase 1/Phase 2
ICG dye imaging for giant cell tumor surgery

This trial uses a special dye (ICG) and a camera to help surgeons see the tumor better during surgery for giant cell tumors of bone in the arms or legs. The goal is to remove all of the tumor while saving as much healthy bone as possible.

Beijing, Beijing Municipality
NCT04723810Recruiting· Phase 1/Phase 2
Test a glowing scan to help surgeons find tumor tissue

This early-stage study tests an intraoperative imaging approach called “TumorGlow” to help surgeons better identify tumor tissue during surgery. It may help improve the completeness of tumor removal and reduce the chance of recurrence in certain patients.

Philadelphia, Pennsylvania
NCT05746104Enrolling by invitation· Phase 1
Testing a glowing dye to find nervous system tumor tissue

This early (Phase 1) study tests whether a glowing dye called indocyanine green helps surgeons better see nervous system tumor tissue during an operation, with the goal of lowering the chance of tumor coming back locally. It’s for adults whose tumor is expected to be removable and at risk for local recurrence.

Philadelphia, Pennsylvania
NCT07825597Recruiting
Using a special dye to see head and neck cancer during surgery

This trial tests a dye called indocyanine green (ICG) that makes cancer cells glow under a special camera during surgery. It may help doctors remove more cancer and leave healthy tissue alone.

St Louis, Missouri

Hear when a new Bone Neoplasms trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.